WHO hopes DRC’s TUMANI vaccine trials will help accelerate the fight against the Bundibugyo Ebola outbreak
The World Health Organisation says it hopes the TUMANI vaccine trials currently underway in the Democratic Republic of Congo, DRC will be able to respond to the urgent scientific questions regarding the current outbreak of the ebola caused by the Bundibugyo virus disease. TUMANI, which means hope in Swahili, is a clinical trial, designed so that several vaccine candidates could be evaluated within one research framework, using a ring-vaccination approach involving contacts of people with confirmed disease. The trials are led by the government of the DRC, integrated into the outbreak response and managed by the Institut National de Recherche Biomédicale, the national public health and biomedical research institute. Thuto Ngobeni has more...
In 1 playlist(s)
Rise & Shine
News headlinesSocial links
Recent clips

AGOA review puts South Africa-US trade ties to the test, with jobs, exports and Africa's economic interests at stake
20:56

Western Sahara faces renewed conflict risks as UN peacekeeping mission ends after Security Council deadlock
13:56

Cameroon opposition condemns suspension of party led by Issa Tchiroma Bakary amid shrinking democratic space
14:19
